Mark W. Linder

62 papers and 1.9k indexed citations i.

About

Mark W. Linder is a scholar working on Pharmacology, Molecular Biology and Cancer Research. According to data from OpenAlex, Mark W. Linder has authored 62 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pharmacology, 21 papers in Molecular Biology and 11 papers in Cancer Research. Recurrent topics in Mark W. Linder’s work include Pharmacogenetics and Drug Metabolism (23 papers), Hormonal Regulation and Hypertension (9 papers) and Cancer Genomics and Diagnostics (9 papers). Mark W. Linder is often cited by papers focused on Pharmacogenetics and Drug Metabolism (23 papers), Hormonal Regulation and Hypertension (9 papers) and Cancer Genomics and Diagnostics (9 papers). Mark W. Linder collaborates with scholars based in United States, Germany and India. Mark W. Linder's co-authors include Roland Valdes, Russell A. Prough, R Valdes, Kristen K. Reynolds, Lori Millner, P E Keck, Nancy Johnson, Yusheng Zhu, Bonny L. Bukaveckas and Andreas Warnke and has published in prestigious journals such as Journal of Biological Chemistry, The FASEB Journal and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Co-authorship network of co-authors of Mark W. Linder i

Fields of papers citing papers by Mark W. Linder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Linder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Linder. The network helps show where Mark W. Linder may publish in the future.

Countries citing papers authored by Mark W. Linder

Since Specialization
Citations

This map shows the geographic impact of Mark W. Linder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Linder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Linder more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2025